These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1658 related items for PubMed ID: 24239208

  • 1. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX, Song W, Chen ZH, Wei JH, Liao YJ, Lei J, Hu M, Chen GZ, Liao B, Lu J, Zhao HW, Chen W, He YL, Wang HY, Xie D, Luo JH.
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [Abstract] [Full Text] [Related]

  • 2. Identifying High-Risk Stage II Colon Cancer Patients: A Three-MicroRNA-Based Score as a Prognostic Biomarker.
    Caritg O, Navarro A, Moreno I, Martínez-Rodenas F, Cordeiro A, Muñoz C, Ruiz-Martinez M, Santasusagna S, Castellano JJ, Monzó M.
    Clin Colorectal Cancer; 2016 Dec; 15(4):e175-e182. PubMed ID: 27247088
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer.
    Bobowicz M, Skrzypski M, Czapiewski P, Marczyk M, Maciejewska A, Jankowski M, Szulgo-Paczkowska A, Zegarski W, Pawłowski R, Polańska J, Biernat W, Jaśkiewicz J, Jassem J.
    Clin Exp Metastasis; 2016 Dec; 33(8):765-773. PubMed ID: 27485175
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
    Liu N, Chen NY, Cui RX, Li WF, Li Y, Wei RR, Zhang MY, Sun Y, Huang BJ, Chen M, He QM, Jiang N, Chen L, Cho WC, Yun JP, Zeng J, Liu LZ, Li L, Guo Y, Wang HY, Ma J.
    Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ, Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L, Chen YP.
    Oncotarget; 2015 Sep 22; 6(28):25093-108. PubMed ID: 26231037
    [Abstract] [Full Text] [Related]

  • 8. Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
    Wei JH, Feng ZH, Cao Y, Zhao HW, Chen ZH, Liao B, Wang Q, Han H, Zhang J, Xu YZ, Li B, Wu JT, Qu GM, Wang GP, Liu C, Xue W, Liu Q, Lu J, Li CX, Li PX, Zhang ZL, Yao HH, Pan YH, Chen WF, Xie D, Shi L, Gao ZL, Huang YR, Zhou FJ, Wang SG, Liu ZP, Chen W, Luo JH.
    Lancet Oncol; 2019 Apr 22; 20(4):591-600. PubMed ID: 30880070
    [Abstract] [Full Text] [Related]

  • 9. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer.
    Mo S, Dai W, Xiang W, Li Y, Feng Y, Zhang L, Li Q, Cai G.
    Carcinogenesis; 2019 Jul 20; 40(7):861-870. PubMed ID: 30933267
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
    Hur K, Toiyama Y, Schetter AJ, Okugawa Y, Harris CC, Boland CR, Goel A.
    J Natl Cancer Inst; 2015 Mar 20; 107(3):. PubMed ID: 25663689
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
    Ecke TH, Stier K, Weickmann S, Zhao Z, Buckendahl L, Stephan C, Kilic E, Jung K.
    Cancer Med; 2017 Oct 20; 6(10):2252-2262. PubMed ID: 28879675
    [Abstract] [Full Text] [Related]

  • 17. Ubiquitin D is an independent prognostic marker for survival in stage IIB-IIC colon cancer patients treated with 5-fluoruracil-based adjuvant chemotherapy.
    Zhao S, Jiang T, Tang H, Cui F, Liu C, Guo F, Lu H, Xue Y, Jiang W, Peng Z, Yan D.
    J Gastroenterol Hepatol; 2015 Apr 20; 30(4):680-8. PubMed ID: 25238407
    [Abstract] [Full Text] [Related]

  • 18. Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer.
    Jacob H, Stanisavljevic L, Storli KE, Hestetun KE, Dahl O, Myklebust MP.
    Oncotarget; 2017 Oct 20; 8(50):87837-87847. PubMed ID: 29152124
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 83.